Alcohol use disorders negatively influence antiretroviral medication adherence among men who have sex with men in Peru

References

• Allen, J. P., Litten, R. Z., Fertig, J. B., & Babor, T. (1997). A review of research on the alcohol use disorders identification test (AUDIT). Alcoholism: Clinical and Experimental Research, 21, 613–619. doi:10.1111/j.1530-0277.1997.tb03811.x
   PubMed Web of Science ®Google Scholar
• Amass, L., Bickel, W. K., Higgins, S. T., & Badger, G. J. (1994). Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sciences, 54, 1215–1228.doi:10.1111/j.1530-0277.1997.tb03811.x
   PubMed Web of Science ®Google Scholar
• Amass, L., Bickel, W. K., Higgins, S. T., & Hughes, J. R. (1994). A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification. Journal of Addictive Diseases, 13, 33–45. doi:10.1300/J069v13n03_04
   PubMed Web of Science ®Google Scholar
• Anand, P., Springer, S. A., Copenhaver, M. M., & Altice, F. L. (2010). Neurocognitive impairment and HIV risk factors: A reciprocal relationship. AIDS and Behavior, 14, 1213–1226. doi:10.1007/s10461-010-9684-1
   PubMed Web of Science ®Google Scholar
• Angst, J., Azorin, J. M., Bowden, C. L., Perugi, G., Vieta, E., Gamma A, …. BRIDGE Study Group (2011). Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: The BRIDGE study. Archives of General Psychiatry, 68, 791–798. doi:10.1001/archgenpsychiatry.2011.87
   PubMed Web of Science ®Google Scholar
• Anton, R. F., O'Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., … Combine Study Research Group, F. T. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: The COMBINE study: A randomized controlled trial. JAMA, 295, 2003–2017. doi:10.1001/jama.295.17.2003
   PubMed Web of Science ®Google Scholar
• Azar, M. M., Springer, S. A., Meyer, J. P., & Altice, F. L. (2010). A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug and Alcohol Dependence, 112, 178–193. doi:10.1016/j.drugalcdep.2010.06.014
   PubMed Web of Science ®Google Scholar
• Babor, T. F., & Higgins-Biddle, J. C. (2001). Brief intervention for hazardous and harmful drinking: A manual for use in primary care. In World Health Organization DoMHaSD, editor. Accessed on May 29, 2013 at: http://whqlibdoc.who.int/hq/2001/who_msd_msb_2001.2016b.pdf.
   Google Scholar
• Babor, T., Delafuente, J., & Saunders, J. (1992). AUDIT: The alcohol use disorders identification test: Guidelines for use in primary health care. Geneva: World Health Organization.
   Google Scholar
• Beach, M. C., Keruly, J., & Moore, R. D. (2006). Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?Journal of General Internal Medicine, 21, 661–665. doi:10.1111/j.1525-1497.2006.00399.x
   PubMed Web of Science ®Google Scholar
• Berger, B. E., Ferrans, C. E., & Lashley, F. R. (2001). Measuring stigma in people with HIV: Psychometric assessment of the HIV stigma scale. Research in Nursing & Health, 24, 518–529. doi:10.1002/nur.10011
   PubMed Web of Science ®Google Scholar
• Beyrer, C., Baral, S. D., van Griensven, F., Goodreau, S. M., Chariyalertsak, S., Wirtz, A. L., & Brookmeyer, R. (2012). Global epidemiology of HIV infection in men who have sex with men. The Lancet, 380, 367–377. doi:10.1016/S0140-6736(12)60821-6
   PubMed Web of Science ®Google Scholar
• Bickel, G., Nord, M., Price, C., Hamilton, W., & Cook, J. (2000). Guide to measuring household food security. Washington, DC: Food and Nutrition Service, US Department of Agriculture.
   Google Scholar
• Binford, M. C., Kahana, S. Y., & Altice, F. L. (2012). A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Current HIV/AIDS Reports, 9, 287–312. doi:10.1007/s11904-012-0134-8
   PubMed Web of Science ®Google Scholar
• Blas, M. M., Alva, I. E., Cabello, R., Carcamo, C., Kurth, A. E., & Thorne, C. (2011). Risk behaviors and reasons for not getting tested for HIV among men who have sex with men: An online survey in Peru. PLoS One, 6, e27334. doi:10.1371/journal.pone.0027334
   PubMed Web of Science ®Google Scholar
• Boyce, S., Barrington, C., Bolaños, H., Arandi, C. G., & Paz-Bailey, G. (2012). Facilitating access to sexual health services for men who have sex with men and male-to-female transgender persons in Guatemala City. Culture, Health and Sexuality, 14, 313–327. doi:10.1080/13691058.2011.639393
   PubMed Web of Science ®Google Scholar
• Boyd, M. A., Zhang, X., Dorr, A., Ruxrungtham, K., Kolis, S., Nieforth, K., … Patel, I. H. (2003). Lack of enzyme-inducing effect of rifampicin on the pharmacokinetics of enfuvirtide. The Journal of Clinical Pharmacology, 43, 1382–1391. doi:10.1177/0091270003259220
   PubMed Web of Science ®Google Scholar
• Braithwaite, R. S., Conigliaro, J., McGinnis, K. A., Maisto, S. A., Bryant, K., & Justice, A. C. (2008). Adjusting alcohol quantity for mean consumption and intoxication threshold improves prediction of nonadherence in HIV patients and HIV-negative controls. Alcoholism: Clinical and Experimental Research, 32, 1645–1651. doi:10.1111/j.1530-0277.2008.00732.x
   PubMed Web of Science ®Google Scholar
• Braithwaite, R. S., McGinnis, K. A., Conigliaro, J., Maisto, S. A., Crystal, S., Day, N., … Justice, A. C. (2005). A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care. Alcoholism: Clinical and Experimental Research, 29, 1190–1197. doi:10.1097/01.ALC.0000171937.87731.28
   PubMed Web of Science ®Google Scholar
• Brigido, L. F. M., Rodrigues, R., Casseb, J., Oliveira, D., Rossetti, M., Menezes, P., & Duarte, A. J. S. (2001). Impact of adherence to antiretroviral therapy in HIV-1–infected patients at a university public service in Brazil. AIDS Patient Care and STDs, 15, 587–593. doi:10.1089/108729101753287685
   PubMed Web of Science ®Google Scholar
• Brislin, R. W. (1970). Back-translation for cross-cultural research. Journal of Cross-Cultural Psychology, 1(3), 185–216. doi:10.1177/135910457000100301
   Web of Science ®Google Scholar
• Cacciola, J. S., Alterman, A. I., Habing, B., & McLellan, A. T. (2011). Recent status scores for version 6 of the addiction severity index (ASI-6). Addiction, 106, 1588–1602. doi:10.1111/j.1360-0443.2011.03482.x
   PubMed Web of Science ®Google Scholar
• Caceres, C. F., Konda, K., Segura, E. R., & Lyerla, R. (2008). Epidemiology of male same-sex behaviour and associated sexual health indicators in low- and middle-income countries: 2003–2007 estimates. Sexually Transmitted Infections, 84(1), i49–i56. doi:10.1136/sti.2008.030569
   PubMedGoogle Scholar
• Chander, G., Himelhoch, S., Fleishman, J. A., Hellinger, J., Gaist, P., Moore, R. D., & Gebo, K. A. (2009). HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care, 21, 655–663. doi:10.1080/09540120802459762
   PubMed Web of Science ®Google Scholar
• Chen, L. Y., Crum, R. M., Martins, S. S., Kaufmann, C. N., Strain, E. C., & Mojtabai, R. (2013). Service use and barriers to mental health care among adults with major depression and comorbid substance dependence. Psychiatry Servey, 64(9), 863–870. doi:10.1176/appi.ps.201200289
   PubMed Web of Science ®Google Scholar
• Chew, L. D., Bradley, K. A., & Boyko, E. J. (2004). Brief questions to identify patients with inadequate health literacy. Family Medicine, 36, 588–594.
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365, 493–505. doi:10.1056/NEJMoa1105243
   PubMed Web of Science ®Google Scholar
• Cook, R. L., Sereika, S. M., Hunt, S. C., Woodward, W. C., Erlen, J. A., & Conigliaro, J. (2001). Problem drinking and medication adherence among persons with HIV infection. Journal of general internal medicine, 16(2), 83–88. doi:10.1111/j.1525-1497.2001.00122.x
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone, N. F., Moore, D. J., Letendre, S., Poehlman Roediger, M., Eberly, L., Weintrob, A., … Hale, B. R. (2013). Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons. Neurology, 80, 371–379. doi:10.1212/WNL.0b013e31827f0776
   PubMed Web of Science ®Google Scholar
• Curioso, W. H., Quistberg, D. A., Cabello, R., Gozzer, E., Garcia, P. J., Holmes, K. K., & Kurth, A. E.. (2009). “It's time for your life”: How should we remind patients to take medicines using short text messages? AMIA Annual Symposium Proceedings, 2009, 129–133.
   Google Scholar
• Curioso, W. H., Kepka, D., Cabello, R., Segura, P., & Kurth, A. E. (2010). Understanding the facilitators and barriers of antiretroviral adherence in Peru: A qualitative study. BMC Public Health, 10(1), 13. doi:10.1186/1471-2458-10-13
   PubMed Web of Science ®Google Scholar
• Curioso, W. H., Kurth, A. E., Cabello, R., Segura, P., & Berry, D. L. (2008, November 6). Usability evaluation of Personal Digital Assistants (PDAs) to support HIV treatment adherence and safer sex behavior in Peru. AMIA Annual Symposium Proceedings, 6, 918.
   Google Scholar
• Deiss, R. G., Clark, J. L., Konda, K. A., Leon, S. R., Klausner, J. D., Caceres, C. F., & Coates, T. J. (2013). Problem drinking is associated with increased prevalence of sexual risk behaviors among men who have sex with men (MSM) in Lima, Peru. Drug and Alcohol Dependence, 132(1–2), 134–139. doi:10.1016/j.drugalcdep
   PubMed Web of Science ®Google Scholar
• Del Pesce, M., Franciolini, B., Censori, B., Bartolini, M., Ancarani, F., Petrelli, E., & Provinciali, L. (1993). Cognitive behavior in asymptomatic (CDC stage II and III) HIV — Seropositive intravenous drug users (IVDUs). The Italian Journal of Neurological Sciences, 14, 619–625. doi:10.1007/BF02339246
   PubMedGoogle Scholar
• Djomand, G., Quaye, S., & Sullivan, P. S. (2014). HIV epidemic among key populations in West Africa. Current Opinion in HIV and AIDS, 9(5), 506–513. doi:10.1097/COH.0000000000000090
   PubMed Web of Science ®Google Scholar
• Elul, B., Basinga, P., Nuwagaba-Biribonwoha, H., Saito, S., Horowitz, D., Nash, D., … Asiimwe, A. (2013). High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. PLoS One, 8, e53586. doi:10.1371/journal.pone.0053586
   PubMed Web of Science ®Google Scholar
• Ezeabogu, I., Copenhaver, M. M., & Potrepka, J. (2012). The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care, 24, 386–393. doi:10.1080/09540121.2011.608794
   PubMed Web of Science ®Google Scholar
• Fleishman, J. A., Sherbourne, C. D., Crystal, S., Collins, R. L., Marshall, G. N., Kelly, M., … Hays, R. D. (2000). Coping, conflictual social interactions, social support, and mood among HIV-infected persons. HCSUS consortium. American Journal of Community Psychology, 28, 421–453. doi:10.1023/A:1005132430171
   PubMed Web of Science ®Google Scholar
• Friedman, M. R., Wei, C., Klem, M. L., Silvestre, A. J., Markovic, N., Stall, R., & Remis, R. S. (2014). HIV infection and sexual risk among men who have sex with men and women (MSMW): A systematic review and meta-analysis. PLoS One, 9(1), e87139. doi:10.1371/journal.pone.0087139
   PubMed Web of Science ®Google Scholar
• Garbutt, J. C., Kranzler, H. R., O'Malley, S. S., Gastfriend, D. R., Pettinati, H. M., Silverman, B. L., … Vivitrex Study Group. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: A randomized controlled trial. JAMA, 293, 1617–1625. doi:10.1001/jama.293.13.1617
   PubMed Web of Science ®Google Scholar
• Gavin, D. R., Ross, H. E., & Skinner, H. A. (1989). Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders British Journal of Addiction, 84(3), 301–307.
   Google Scholar
• Ghanem, K. G., Hutton, H. E., Zenilman, J. M., Zimba, R., & Erbelding, E. J. (2005). Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sexually Transmitted Infections, 81, 421–425. doi:10.1136/sti.2004.013193
   PubMed Web of Science ®Google Scholar
• Giordano, T. P., Gifford, A. L., White, A. C., Jr., Suarez-Almazor, M. E., Rabeneck, L., Hartman, C., … Morgan, R. O. (2007). Retention in care: A challenge to survival with HIV infection. Clinical Infectious Diseases, 44, 1493–1499. doi:10.1086/516778
   PubMed Web of Science ®Google Scholar
• Giordano, T. P., Guzman, D., Clark, R., Charlebois, E. D., & Bangsberg, D. R. (2004). Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clinical Trials, 5, 74–79. doi:10.1310/JFXH-G3X2-EYM6-D6UG
   PubMed Web of Science ®Google Scholar
• Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M., & Williams, B. G. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model., 373, 48–57.
   Google Scholar
• Grodensky, C. A., Golin, C. E., Ochtera, R. D., & Turner, B. J. (2012). Systematic review: Effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases. Journal of Studies on Alcohol and Drugs, 73, 899–910.
   PubMed Web of Science ®Google Scholar
• Halkitis, P. N., Shrem, M. T., Zade, D. D., & Wilton, L. (2005). The physical, emotional and interpersonal impact of HAART: Exploring the realities of HIV seropositive individuals on combination therapy. Journal of Health Psychology, 10, 345–358. doi:10.1177/1359105305051421
   PubMed Web of Science ®Google Scholar
• Hasin, D. S., Goodwin, R. D., Stinson, F. S., & Grant, B. F. (2005). Epidemiology of major depressive disorder: Results from the national epidemiologic survey on alcoholism and related conditions. Archives of General Psychiatry, 62, 1097–1106. doi:10.1001/archpsyc.62.10.1097
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Grant, I., Butters, N., White, D. A., Kirson, D., Atkinson, J. H., … Abramson, I. (1995). The HNRC 500-Neuropsychology of Hiv infection at different disease stages. Journal of the International Neuropsychological Society, 1, 231–251. doi:10.1017/S1355617700000230
   PubMedGoogle Scholar
• Hendershot, C. S., Stoner, S. A., Pantalone, D. W., & Simoni, J. M. (2009). Alcohol use and antiretroviral adherence: Review and meta-analysis. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52, 180–202. doi:10.1097/QAI.0b013e3181b18b6e
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. N., Mason, K. I., … Stefaniak, M. (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950. doi:10.1212/01.WNL.0000038347.48137.67
   PubMed Web of Science ®Google Scholar
• Jacob, S. T., Baeten, J. M., Hughes, J. P., Peinado, J., Wang, J., Sanchez, J., … Celum, C. (2011). A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial. AIDS and Behavior, 15, 897–904. doi:10.1007/s10461-010-9853-2
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Amaral, C. M., White, D., Swetsze, C., Pope, H., Kalichman, M. O., … Eaton, L. (2009). Prevalence and clinical implications of interactive toxicity beliefs regarding mixing alcohol and antiretroviral therapies among people living with HIV/AIDS. AIDS Patient Care and STDs, 23, 449–454. doi:10.1089/apc.2008.0184
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Catz, S., & Ramachandran, B. (1999). Barriers to HIV/AIDS treatment and adherence among African-American adults with disadvantaged education. Journal of the National Medical Association, 91, 439–446.
   PubMed Web of Science ®Google Scholar
• Kalichman, S. C., Simbayi, L. C., Kaufman, M., Cain, D., & Jooste, S. (2007). Alcohol use and sexual risks for HIV/AIDS in sub-Saharan Africa: Systematic review of empirical findings. Prevention Science, 8, 141–151. doi:10.1007/s11121-006-0061-2
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 62, 617–627. doi:10.1001/archpsyc.62.6.617
   PubMed Web of Science ®Google Scholar
• King, A. C., de Wit, H., McNamara, P. J., & Cao, D. (2011). Rewarding, stimulant, and sedative alcohol responses and relationship to future binge drinking. Archives of General Psychiatry, 68, 389–399. doi:10.1001/archgenpsychiatry.2011.26
   PubMed Web of Science ®Google Scholar
• Krishnan, A., Ferro, E. G., Weikum, D., Vagenas, P., Lama, J. R., et al. (in press). Communication technology use and mhealth acceptance among HIV-infected men who have sex with men in Peru: Implications for HIV prevention and treatment. AIDS Care.
   Web of Science ®Google Scholar
• Krüsi, A., Wood, E., Montaner, J., & Kerr, T. (2010). Social and structural determinants of HAART access and adherence among injection drug users. International Journal of Drug Policy, 21(1), 4–9. doi:10.1016/j.drugpo.2009.08.003
   PubMed Web of Science ®Google Scholar
• Kurth, A. E., Curioso, W. H., Ngugi, E., McClelland, L., Segura, P., Cabello, R., & Berry, D. L. (2007). Personal digital assistants for HIV treatment adherence, safer sex behavior support, and provider training in resource-constrained settings. AMIA Annual Symposium Proceedings, 1018.
   PubMedGoogle Scholar
• Lenore, S. R. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401. doi:10.1177/014662167700100306
   Google Scholar
• Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS, 16, 767–774. doi:10.1097/00002030-200203290-00012
   PubMed Web of Science ®Google Scholar
• Ludford, K. T., Vagenas, P., Lama, J. R., Peinado, J., Gonzales, P., Leiva, R., … Grinsztejn, B. G. J. (2013). Screening for drug and alcohol use disorders and their association with HIV-related sexual risk behaviors among men who have sex with men in Peru. PLoS One, 8, e69966. doi:10.1371/journal.pone.0069966
   PubMed Web of Science ®Google Scholar
• Malta, M., Magnanini, M. M. F., Strathdee, S. A., & Bastos, F. I. (2010). Adherence to antiretroviral therapy among HIV-infected drug users: A meta-analysis. AIDS and Behavior, 14, 731–747. doi:10.1007/s10461-008-9489-7
   PubMed Web of Science ®Google Scholar
• Margolin, A., Avants, S. K., Warburton, L. A., & Hawkins, K. A. (2002). Factors affecting cognitive functioning in a sample of human immunodeficiency virus-positive injection drug users. AIDS Patient Care and STDs, 16, 255–267. doi:10.1089/10872910260066697
   PubMed Web of Science ®Google Scholar
• Martin, E. M., Nixon, H., Pitrak, D. L., Weddington, W., Rains, N. A., Nunnally, G., … Bechara, A. (2007). Characteristics of prospective memory deficits in HIV-seropositive substance-dependent individuals: Preliminary observations. Journal of Clinical and Experimental Neuropsychology, 29, 496–504. doi:10.1080/13803390600800970
   PubMed Web of Science ®Google Scholar
• Mayston, R., Kinyanda, E., Chishinga, N., Prince, M., & Patel, V. (2012). Mental disorder and the outcome of HIV/AIDS in low-income and middle-income countries: A systematic review. AIDS, 26, S117–S135. doi:10.1097/QAD.0b013e32835bde0f
   PubMedGoogle Scholar
• McKirnan, D. J., Ostrow, D. G., & Hope, B. (1996). Sex, drugs and escape: A psychological model of HIV-risk sexual behaviours. AIDS Care, 8, 655–670. doi:10.1080/09540129650125371
   PubMed Web of Science ®Google Scholar
• McNaghten, A. D., Hanson, D. L., Dworkin, M. S., & Jones, J. L. (2003). Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. JAIDS Journal of Acquired Immune Deficiency Syndromes, 32, 499–505. doi:10.1097/00126334-200304150-00006
   PubMed Web of Science ®Google Scholar
• Muessig, K. E., Smith, M. K., Powers, K. A., Lo, Y. R., Burns, D. N., Grulich, A. E., … Cohen, M. S. (2012). Does ART prevent HIV transmission among MSM? AIDS, 26, 2267–2273. doi:10.1097/QAD.0b013e328355713d
   PubMed Web of Science ®Google Scholar
• Muraguri, N., Temmerman, M., & Geibel, S. (2012). A decade of research involving men who have sex with men in sub-Saharan Africa: Current knowledge and future directions. SAHARA-J: Journal of Social Aspects of HIV/AIDS, 9(3), 137–147. doi:10.1080/17290376.2012.744176
   PubMed Web of Science ®Google Scholar
• Nemeroff, C. J., Hoyt, M. A., Huebner, D. M., & Proescholdbell, R. J. (2008). The cognitive escape scale: Measuring HIV-related thought avoidance. AIDS and Behavior, 12, 305–320. doi:10.1007/s10461-007-9345-1
   PubMed Web of Science ®Google Scholar
• Newman, C. E., Bonar, M., Greville, H. S., Thompson, S. C., Bessarab, D., & Kippax, S. C. (2007). Barriers and incentives to HIV treatment uptake among Aboriginal people in Western Australia. AIDS, 21(1), S13–S17. doi:10.1097/01.aids.0000255080.46976.18
   PubMedGoogle Scholar
• Ngoh, L. N. (2009). Health literacy: A barrier to pharmacist–patient communication and medication adherence. Journal of the American Pharmacists Association, 49, e132–e146; quiz e139–e147. doi:10.1331/JAPhA.2009.07075
   PubMed Web of Science ®Google Scholar
• O'Donnell, W. E., De Soto, C. B., & De Soto, J. L. (1993). Validity and reliability of the revised neuropsychological impairment scale (NIS). Journal of Clinical Psychology, 49, 372–382. doi:10.1002/1097-4679(199305)49:3%3C372::AID-JCLP2270490311%3E3.0.CO;2-K
   PubMed Web of Science ®Google Scholar
• Palepu, A., Tyndall, M. W., Li, K., Yip, B., O'Shaughnessy, M. V., Schechter, M. T., … Hogg, R.S. (2003). Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy. Journal of Urban Health: Bulletin of the New York Academy of Medicine, 80, 667–675.
   PubMed Web of Science ®Google Scholar
• Parsons, J. T., Golub, S. A., Rosof, E., & Holder, C. (2007). Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 46, 443–450. doi:10.1097/QAI.0b013e318158a461
   PubMed Web of Science ®Google Scholar
• Reynolds, S. J., Makumbi, F., Nakigozi, G., Kagaayi, J., Gray, R. H., Wawer, M., … Serwadda, D. (2011). HIV-1 transmission among HIV-1 discordant couples before and after the introduction of antiretroviral therapy. AIDS, 25, 473–477.
   PubMed Web of Science ®Google Scholar
• Rivest, J., Jutras-Aswad, D., & Shapiro, P. A. (2013). Treating the “unhealthy alcohol user” on medical wards: Beyond withdrawal. Journal of Psychiatric Practice, 19, 213–226. doi:10.1097/01.pra.0000430505.52391.48
   PubMed Web of Science ®Google Scholar
• Samet, J. H., Horton, N. J., Meli, S., Freedberg, K. A., & Palepu, A. (2004). Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems. Alcoholism: Clinical and Experimental Research, 28, 572–577. doi:10.1097/01.ALC.0000122103.74491.78
   PubMed Web of Science ®Google Scholar
• Sankar, A., Wunderlich, T., Neufeld, S., & Luborsky, M. (2007). Sero-positive African Americans’ beliefs about alcohol and their impact on anti-retroviral adherence. AIDS and Behavior, 11, 195–203. doi:10.1007/s10461-006-9144-0
   PubMed Web of Science ®Google Scholar
• Sato, S., & Yeh, T. L. (2013). Challenges in treating patients with major depressive disorder: The impact of biological and social factors. CNS Drugs, 27(Suppl. 1), 5–10. doi:10.1007/s40263-012-0028-8
   Google Scholar
• Saunders, J. B., Aasland, O. G., Babor, T. F., de la Fuente, J. R., & Grant, M. (1993). Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction, 88, 791–804. doi:10.1111/j.1360-0443.1993.tb02093.x
   PubMed Web of Science ®Google Scholar
• Silveira, M. P., Guttier, M. C., Pinheiro, C. A., Pereira, T. V., Cruzeiro, A. L., & Moreira, L. B. (2012). Depressive symptoms in HIV-infected patients treated with highly active antiretroviral therapy. Revista Brasileira de Psiquiatria, 34, 162–167. doi:10.1590/S1516-44462012000200008
   PubMed Web of Science ®Google Scholar
• Springer, S. A., Altice, F. L., Herme, M., & Di Paola, A. (2014). Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for alcohol dependent and hazardous drinking prisoners with HIV who are transitioning to the community. Contemporary Clinical Trials, 37, 209–218. doi:10.1016/j.cct.2013.12.006
   PubMed Web of Science ®Google Scholar
• Springer, S. A., Dushaj, A., & Azar, M. M. (2012). The impact of DSM-IV mental disorders on adherence to combination antiretroviral therapy among adult persons living with HIV/AIDS: A systematic review. AIDS and Behavior, 16, 2119–2143. doi:10.1007/s10461-012-0212-3
   PubMed Web of Science ®Google Scholar
• Stall, R., & Purcell, D. W. (2000). Intertwining epidemics: A review of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS and Behavior, 4, 181–192. doi:10.1023/A:1009516608672
   Google Scholar
• Teixeira, C., Dourado, M. D. L., Santos, M. P., & Brites, C. (2013). Impact of use of alcohol and illicit drugs by AIDS patients on adherence to antiretroviral therapy in Bahia, Brazil. AIDS Research and Human Retroviruses, 29, 799–804. doi:10.1089/aid.2012.0296
   PubMed Web of Science ®Google Scholar
• Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., … Nachega J. B. (2012). Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: Evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Annals of Internal Medicine, 156, 817–833. doi:10.7326/0003-4819-156-11-201206050-00419
   PubMed Web of Science ®Google Scholar
• Tozzi, V., Balestra, P., Galgani, S., Narciso, P., Ferri, F., Sebastiani, G., … Benedetto, A. (1999). Positive and sustained effects of highly active antiretroviral therapy on HIV-1-associated neurocognitive impairment. AIDS, 13, 1889–1897. doi:10.1097/00002030-199910010-00011
   PubMed Web of Science ®Google Scholar
• Traore, A. K., Thiero, O., Dao, S., Kounde, F. F. C., & Faye, O. (2011). Impact of low dose naltrexone (LDN) on antiretroviral therapy (ART) treated HIV+ adults in Mali: A single blind randomized clinical trial. Journal of AIDS and HIV Research, 3, 189–198.
   Google Scholar
• Tucker, J. S., Burnam, M. A., Sherbourne, C. D., Kung, F.-Y., & Gifford, A. L. (2003). Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. The American Journal of Medicine, 114, 573–580. doi:10.1016/S0002-9343(03)00093-7
   PubMed Web of Science ®Google Scholar
• Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F.-Y., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23, 363–370. doi:10.1037/0278-6133.23.4.363
   PubMed Web of Science ®Google Scholar
• Vagenas, P., Di Paola, A., Herme, M., Lincoln, T., Skiest, D. J., Altice, F. L., & Springer, S. A. (2014). An evaluation of hepatitic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended-release naltrexone. Journal of Substance Abuse Treatment, 47(1), 35–40.
   PubMed Web of Science ®Google Scholar
• Vagenas, P., Lama, J. R., Ludford, K. T., Gonzales, P., Sanchez, J., & Altice, F. L. (2013). A systematic review of alcohol use and sexual risk-taking in Latin America. Revista Panamericana De Salud Pública, 34, 267–274.
   PubMed Web of Science ®Google Scholar
• Vagenas, P., Ludford, K. T., Gonzales, P., Peinado, J., Cabezas, C., Gonzales, F., … Peruvian HIV Sentinel Surveillance Working Group (2013). Being unaware of being HIV-infected is associated with alcohol use disorders and high-risk sexual behaviors among men who have sex with men in Peru. AIDS and Behavior, 18(1), 120–127. doi:10.1007/s10461-013-0504-2
   Web of Science ®Google Scholar
• Wang, D., Hicks, C. B., Goswami, N. D., Tafoya, E., Ribeiro, R. M., Cai, F., … Gao, F. (2011). Evolution of drug-resistant viral populations during interruption of antiretroviral therapy. Journal of Virology, 85, 6403–6415. doi:10.1128/JVI.02389-10
   PubMed Web of Science ®Google Scholar
• Watson, B., Conigrave, K., Wallace, C., Whitfield, J., Wurst, F., & Haber, P. (2007). Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment. Drug and Alcohol Review, 26, 231–239. doi:10.1080/09595230701247681
   PubMed Web of Science ®Google Scholar
• Weinrieb, R. M., & O'Brien, C. P. (2004). A case report of naltrexone for alcoholism in a liver transplant recipient: Side effects and safety. American Journal on Addictions, 13, 495–497. doi:10.1080/10550490490512870
   PubMed Web of Science ®Google Scholar
• Weinrieb, R. M., Van Horn, D. H. A., McLellan, A. T., Alterman, A. I., Calarco, J. S., O'brien, C. P., & Lucey, M. R. (2001). Alcoholism treatment after liver transplantation: Lessons learned from a clinical trial that failed. Psychosomatics, 42(2), 110–116. doi:10.1176/appi.psy.42.2.110
   PubMed Web of Science ®Google Scholar
• Weiser, S. D., Frongillo, E. A., Ragland, K., Hogg, R. S., Riley, E. D., & Bangsberg, D. R. (2009). Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. Journal of General Internal Medicine, 24(1), 14–20. doi:10.1007/s11606-008-0824-5
   PubMed Web of Science ®Google Scholar
• Westergaard, R. P., Ambrose, B. K., Mehta, S. H., & Kirk, G. D. (2012). Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: A survey of North American HIV providers. Journal of the International AIDS Society, 15(1), 10. doi:10.1186/1758-2652-15-10
   PubMed Web of Science ®Google Scholar
• Wood, E., Kerr, T., Marshall, B. D. L., Li, K., Zhang, R., Hogg, R. S., … Montaner, J. S. G. (2009). Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: Prospective cohort study. BMJ, 338, b1649. doi:10.1136/bmj.b1649
   PubMed Web of Science ®Google Scholar
• Wood, E., Milloy, M. J., & Montaner, J. S. G. (2012). HIV treatment as prevention among injection drug users. Current Opinion in HIV and AIDS, 7, 151–156. doi:10.1097/COH.0b013e32834f9927
   PubMed Web of Science ®Google Scholar
• Woolf, S. E., & Maisto, S. A. (2009). Alcohol use and risk of HIV infection among men who have sex with men. AIDS and Behavior, 13, 757–782. doi:10.1007/s10461-007-9354-0
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2011). Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. Recommendations for a public health approach. Geneva: Author.
   Google Scholar
• Zarkin, G. A., Bray, J. W., Aldridge, A., Mitra, D., Mills, M. J., Couper, D. J., … COMBINE Cost-Effectiveness Research Group. (2008). Cost and cost-effectiveness of the COMBINE study in alcohol-dependent patients. Archives of General Psychiatry, 65, 1214–1221. doi:10.1001/archpsyc.65.10.1214
   PubMed Web of Science ®Google Scholar